Report Highlights

France Medical Device Connectivity: Market Overview

The French medical device connectivity market is fundamentally shaped by the state's central role in healthcare financing and digital infrastructure planning. Unlike the US market, where private payer incentives drove early EHR adoption, France's trajectory has been determined by the Agence du Numérique en Santé (ANS) and successive national digital health strategies. The market reached USD 1.42 billion in 2024, structured around three dominant segments: device-to-EHR integration middleware, telemetry and patient monitoring networks, and clinical data management platforms. Public hospitals, operating under the Groupements Hospitaliers de Territoire framework introduced by the Loi de modernisation du système de santé (Loi Touraine, 2016), represent approximately 70% of end-user demand.

Private sector dynamism has been concentrated in interoperability software and cloud-based data platforms, where firms such as Dedalus, Cerner, and Capsule Technologies have competed for multi-year integration contracts. Hardware connectivity—bedside monitors, infusion pump data capture, ventilator telemetry—remains dominated by Philips, Siemens Healthineers, and GE HealthCare, all of which operate dedicated French subsidiaries with local regulatory compliance teams. The government's Feuille de route du numérique en santé 2023–2027 has codified connectivity as a national infrastructure priority, effectively guaranteeing sustained procurement even through budget consolidation cycles, and distinguishing France from peers such as Italy and Spain where connectivity investment remains discretionary.

Policy-Driven Growth in French Medical Device Connectivity

The primary policy engine is the Ségur du Numérique en Santé programme, launched in 2021 and administered by the ANS and the Direction Générale de l'Offre de Soins (DGOS). Ségur allocated EUR 2 billion across healthcare digitisation, with a dedicated connectivity vague (wave) targeting device-to-system interoperability. Hospitals qualifying under Wave 1 received direct subsidies covering up to 70% of eligible integration project costs, conditional on deploying ANS-certified solutions. This certification requirement, tied to the Cadre d'Interopérabilité des Systèmes d'Information de Santé (CI-SIS) standard, directly channels procurement toward compliant vendors, creating a structured demand pipeline that is administratively enforced rather than market-contingent.

The second mechanism is the mandatory adoption of the Dossier Médical Partagé (DMP) as the national shared medical record, now integrated into Mon Espace Santé, the patient-facing health portal launched in February 2022. Every connected device producing clinical data must feed into DMP-compatible pathways by 2026 under ANS technical guidelines, forcing hospitals to upgrade or replace non-compliant connectivity infrastructure. Third, the Programme National de Sécurité du Système d'Information de Santé (PN-SSIS), managed by the Agence Nationale de la Sécurité des Systèmes d'Information (ANSSI), mandates cybersecurity certification for all networked medical devices under the NIS2 transposition into French law (Ordonnance n°2024-821), requiring vendors to complete ANSSI qualification procedures and driving a new compliance investment cycle across all hospital tiers by Q4 2025.

Regulatory Barriers and Compliance Costs

Market entry is gated by the ANS Référencement process, which certifies software and connectivity platforms against CI-SIS interoperability standards. Referencing timelines routinely extend 12 to 18 months for new entrants, during which vendors cannot participate in public tenders at major GHT institutions. The Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) administers EU MDR (Regulation 2017/745) conformity at the national level, and its post-market surveillance obligations for Class IIa and IIb connected devices add an estimated EUR 200,000 to EUR 500,000 in annual compliance costs per product line, a burden that disproportionately disadvantages mid-sized domestic developers relative to Philips and Siemens Healthineers, which amortise these costs across pan-European portfolios.

Local content requirements do not exist in formal statutory terms, but public procurement under the Code de la commande publique effectively advantages vendors with established French legal entities, local support infrastructure, and French-language technical documentation certified by ANS. The ANSSI NIS2 qualification process, mandatory for devices handling personal health data on public hospital networks, imposes security audits costing EUR 80,000 to EUR 150,000 per product and requires requalification every three years or after significant software updates. For vendors managing portfolios of connected devices across multiple hospital categories, cumulative ANSSI qualification costs constitute a structural barrier that reinforces the dominance of large incumbent integrators already embedded in GHT procurement frameworks.

Policy-Created Opportunities in France

Ségur du Numérique Wave 2, announced in 2023 with EUR 600 million in additional allocation targeting médico-social and ambulatory care settings, opens a largely untapped connectivity procurement segment. Établissements d'Hébergement pour Personnes Âgées Dépendantes (EHPAD) and home care networks are now eligible for subsidised device integration funding for the first time, requiring vendors to adapt hospital-grade connectivity platforms to distributed, lower-bandwidth environments. Vendors holding existing ANS certification for acute care settings carry a direct procurement advantage in this wave, as the DGOS has indicated preference for extending existing certified ecosystems rather than introducing new uncertified platforms, compressing the competitive field significantly for new entrants targeting this segment.

The France 2030 national investment plan allocates EUR 650 million specifically to health innovation, including a dedicated pillar for connected medical technologies under the Bpifrance-administered Innovation Santé 2030 programme. This provides non-dilutive grant funding of up to EUR 5 million per project for French-registered entities developing AI-integrated device connectivity platforms. Additionally, the forthcoming European Health Data Space (EHDS) regulation, expected to impose cross-border health data exchange obligations by 2027, creates a first-mover opportunity for vendors who pre-build EHDS-compliant data architectures now. France's ANS has already published draft technical alignment guidelines between CI-SIS and the EHDS primary use framework, and vendors achieving dual compliance before the 2026 deadline gain a durable procurement position across both domestic and EU cross-border procurement frameworks.

Market at a Glance

Leading Market Participants

• Philips France
• Siemens Healthineers France
• GE HealthCare France
• Capsule Technologies
• Cerner (Oracle Health)
• Dedalus France
• InterSystems France
• Draeger France
• Nuvolo (ServiceNow)
• Maincare Solutions

Regulatory and Policy Environment

The primary legislative framework governing medical device connectivity in France is EU MDR (Regulation 2017/745), transposed and enforced nationally by the ANSM, supplemented by the Loi relative à l'organisation et à la transformation du système de santé (Loi Buzyn, 2019), which mandated nationwide EHR interoperability and established the legal basis for Mon Espace Santé and the DMP. The ANS Cadre d'Interopérabilité des Systèmes d'Information de Santé (CI-SIS), currently at version 2.1, defines the technical standards — HL7 FHIR R4, IHE profiles, and DICOM extensions — against which all connectivity platforms must demonstrate compliance before receiving public procurement eligibility. Upcoming CI-SIS version 2.2, expected in Q3 2025, introduces mandatory SMART on FHIR authentication requirements, forcing all incumbent certified vendors to update platform architectures within 12 months of publication.

Compared to regional peers, France's framework is the most prescriptive in continental Europe. Germany's DiGA framework and Spain's SNS interoperability initiatives are voluntary or incentive-based, whereas ANS certification is a hard procurement gate in France. The ANSSI NIS2 transposition (Ordonnance n°2024-821), effective October 2024, places hospital networks and their connected device suppliers under enhanced cybersecurity obligations, including mandatory incident reporting within 24 hours and triennial security audits. The Haute Autorité de Santé (HAS) additionally evaluates connected medical devices under its référentiel de bonnes pratiques for digital health tools, and unfavourable HAS assessments materially impair reimbursement prospects under the Nomenclature des Actes de Biologie Médicale, creating a multi-agency compliance burden that is structurally more complex than any comparable EU member state market.

Long-Term Policy Outlook for French Medical Device Connectivity

By 2028, the European Health Data Space regulation will impose binding obligations on France to enable cross-border sharing of device-generated clinical data under the primary use framework, requiring ANS to revise CI-SIS to accommodate EHDS data governance rules. This creates a mandatory infrastructure upgrade cycle affecting every connected device deployed in public hospitals, because current HL7 FHIR R4 implementations will require EHDS-specific consent management modules and secondary use opt-out mechanisms not currently specified in CI-SIS 2.1. Vendors that develop modular EHDS compliance layers before the 2026 French transposition deadline will be positioned to win upgrade contracts across the entire GHT network without competitive re-tendering, as the DGOS has signalled it will treat EHDS readiness as a pass-fail procurement criterion.

Domestically, the Feuille de route du numérique en santé 2023–2027 commits France to achieving full device-to-DMP data continuity across all licensed healthcare facilities by 2027, which requires connectivity deployments in approximately 3,200 ambulatory and médico-social facilities currently operating without certified integration. The DGOS is expected to legislate minimum connectivity standards for these facilities through a décret en Conseil d'État by late 2025, creating a new mandatory procurement category. Simultaneously, France's national AI health strategy, articulated under the Grand Défi IA Santé, will drive demand for connectivity platforms capable of real-time device data streaming to AI inference engines, a technical requirement absent from current CI-SIS specifications but flagged in the ANS 2026 roadmap as a forthcoming mandatory capability for tier-one hospital certifications.

Market Segmentation

By Component

• Hardware (Connectivity Modules, Gateways)
• Software (Integration Platforms, Middleware)
• Services (Implementation, Managed Services)
• Cybersecurity Solutions

By Device Type

• Patient Monitoring Systems
• Infusion Pumps
• Ventilators and Respiratory Devices
• Diagnostic Imaging Equipment
• Point-of-Care Testing Devices
• Wearable Medical Devices

By End User

• Public University Hospitals (CHU)
• Groupements Hospitaliers de Territoire (GHT)
• Private Clinics
• EHPAD and Long-Term Care Facilities
• Ambulatory and Home Care Settings

By Connectivity Technology

• Wired (Ethernet, USB)
• Wireless LAN (Wi-Fi)
• Bluetooth and BLE
• Cellular (4G/5G)
• FHIR-Based Cloud Integration

Frequently Asked Questions

Q1. What is the ANS CI-SIS standard and why is it mandatory for market entry? ▼

The Cadre d'Interopérabilité des Systèmes d'Information de Santé (CI-SIS), published and maintained by the Agence du Numérique en Santé, defines the HL7 FHIR, IHE, and DICOM technical standards all connectivity platforms must meet to receive ANS referencing. Without ANS referencing, vendors are legally ineligible to participate in public hospital procurement tenders under the Code de la commande publique.

Q2. How does the Ségur du Numérique en Santé programme affect procurement decisions? ▼

Ségur provides direct subsidies covering up to 70% of eligible connectivity project costs for public hospitals, but funding is conditional on deploying exclusively ANS-certified solutions. This subsidy structure makes certification status the primary procurement filter, overriding price competitiveness for non-certified vendors.

Q3. What cybersecurity obligations apply to connected medical devices in France? ▼

The transposition of the NIS2 Directive via Ordonnance n°2024-821, effective October 2024, requires networked medical devices operating in public hospital environments to meet ANSSI qualification standards, including mandatory 24-hour incident reporting and triennial security audits. Non-compliant devices cannot legally operate on public hospital networks after the grace period ends in Q4 2025.

Q4. How does ANSM enforce EU MDR compliance for connectivity-enabled devices? ▼

The ANSM conducts post-market surveillance of Class IIa and above connected devices under Articles 83–92 of EU MDR 2017/745, requiring manufacturers to submit Periodic Safety Update Reports and maintain vigilance reporting systems. ANSM has the authority to suspend market access for non-compliant devices pending corrective action, making local regulatory representation essential.

Q5. What impact will the European Health Data Space have on French connectivity vendors? ▼

EHDS will require all connected devices in French public hospitals to support cross-border primary use data sharing with EHDS-mandated consent management modules, a technical requirement not currently covered by CI-SIS 2.1. Vendors must build EHDS-compliant architecture before the anticipated 2026 French transposition deadline to retain public procurement eligibility.